JabezDolz

NVCR primed for an extended run

做多
NASDAQ:NVCR   NovoCure Limited
Kept the chart simple but there are a lot of bullish aspects at play here:

- ready for markup after an accumulation phase
- coming off a wave 5 correction apprx. 0.786 off the highs last June
- looking at weekly chart you’ll see a larger running flat structure
- earnings as a catalyst and overall great company!

*Initial Target by Apr 14 = 99
** Target range by 5/20/2022 = 108-116

Would love to hear your thoughts on this.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。